Retinopathy is associated with increased mortality risk in general populations.
Blood culture results poorly discriminate the mortality risk in critically ill patients with sepsis.
It has been identified as a prognostic marker, stratifying the mortality risk in patients with sepsis.
Renal disease conferred additional mortality risk in established high-risk clinical subgroups.
These comorbidities similarly increase morbidity and mortality risk in HFpEF and HFrEF patients.
Substantial variability in hemoglobin levels has been associated with increased mortality risk in hemodialysis patients.
Coronary artery calcification (CAC) is associated with increased mortality risk in the general population.
Hyperglycemia, elevated glycemic variability and hypoglycemia, were associated with an increased mortality risk in critically ill patients [4 6].
As based on baseline parameters, however, it may not reflect the change in mortality risk in response to initial therapies.
Conclusions: Intravenous glutamine increases mortality risk in ICU patients with severe sepsis, although it reduces risk of new infections.
In particular, weight and position significantly influenced mortality risk in NFL players [19, 49, 50, 61 63, 68].
